CD8A and neoplasm: Accelerated tumor growth was accompanied by metabolic perturbations in CD8+ TILs that impaired their anti-tumor activity, including elevated STAT3 signaling, increased Cpt1b expression, and increased fatty acid oxidation at the expense of glycolysis (23).